Bio-Rad Laboratories | Srodki Pieniężne I Ekwiwalent



Cash And Equivalent Zmiana Data
Abbott USD 7.62B 58M 2024-12
Agilent USD 1.47B 138M 2025-01
Becton, Dickinson and Co. USD 711M 1.01B 2024-12
Bio Techne USD 177.55M 9.99M 2024-12
Bio-Rad Laboratories USD 488.1M 77.72M 2024-12
Bruker USD 183.4M 35.3M 2024-12
Charles River Laboratories USD 194.61M 15.56M 2024-12
Danaher USD 2.08B 549M 2024-12
Exact Sciences USD 5.34M 748K 2024-12
General Electric USD 13.62B 295M 2024-12
Hologic USD 1.78B 378.1M 2024-12
Illumina USD 1.13B 258M 2024-12
IQVIA Holdings USD 1.7B 130M 2024-12
Laboratory Of America USD 1.52B 1.4M 2024-12
Merck USD 13.24B 1.35B 2024-12
Mettler Toledo International USD 59.36M 12.21M 2024-12
Myriad Genetics USD 102.4M 2.5M 2024-12
Quest Diagnostics USD 549M 215M 2024-12
Repligen USD 783.96M 25.19M 2024-09
Revvity USD 1.16B 66.38M 2024-12
Roche Holding CHF 6.98B 2.15B 2024-12
Siemens EUR 13.93B 4.77B 2024-12
Standard Biotools USD 166.73M 43.92M 2024-12
Thermo Fisher Scientific USD 4.01B 636M 2024-12
Tosoh JPY 133.9B 10.22B 2024-12
Waters USD 324.42M 6.09M 2024-12



Bio-Rad Laboratories Srodki Pieniężne I Ekwiwalent - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Mar 2025.